Lv51
866 积分 2024-10-24 加入
Selected biologic markers of inflammation and activity of Crohn's disease
1个月前
已完结
Pharmacokinetics and Exposure Response Relationships of Ustekinumab in Patients With Crohn's Disease
1个月前
已完结
Both IL-12p70 and IL-23 are synthesized during active Crohn's disease and are down-regulated by treatment with anti-IL-12 p40 monoclonal antibody
1个月前
已完结
Guselkumab for the Treatment of Crohn's Disease: Induction Results From the Phase 2 GALAXI-1 Study
2个月前
已完结
Adverse events in IBD: to stop or continue immune suppressant and biologic treatment
3个月前
已完结
Adverse events in IBD: to stop or continue immune suppressant and biologic treatment
3个月前
已关闭
Biologic agents for IBD: practical insights
3个月前
已完结
Locally injected Infliximab ameliorates murine DSS colitis: differences in serum and intestinal levels of drug between healthy and colitic mice
6个月前
已完结
The association of tissue anti-TNF drug levels with serological and endoscopic disease activity in inflammatory bowel disease: the ATLAS study
6个月前
已完结
The association of tissue anti-TNF drug levels with serological and endoscopic disease activity in inflammatory bowel disease: the ATLAS study
6个月前
已完结
皖公网安备34019202002308
